Kytopen seeks to expand patient access to the next generation of living medicines through scalable genome engineering platforms by solving cell therapy manufacturing problems at the discovery stage
Kytopen seeks to expand patient access to the next generation of living medicines through scalable genome engineering platforms by solving cell therapy manufacturing problems at the discovery stage. Their non-viral gene delivery platform empowers researchers and developers to accelerate drug discovery, expedite optimization, and remove barriers to biomanufacturing scaling.